Tech Company Financing Transactions

WaVe Life Sciences Funding Round

On 8/18/2015, WaVe Life Sciences landed $66 million in Series B investment from Foresite Capital, Cormorant Asset Management and Fidelity Management & Research Company.

Transaction Overview

Company Name
Announced On
8/18/2015
Transaction Type
Venture Equity
Amount
$66,000,000
Round
Series B
Proceeds Purpose
WAVE expects to use the proceeds from the Series B financing to continue to evolve its chemistry platform and advance a broad pipeline of stereopure nucleic acid therapeutics, including candidates for Huntington's disease and Duchenne muscular dystrophy, across a breadth of oligonucleotide modalities, including RNAi, antisense and exon-skipping, among others. The company plans to file its first INDs by the end of 2016.

Company Information

Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
733 Concord Ave.
Cambridge, MA 02138
USA
Email Address
Overview
WaVe Life Sciences (NASDAQ: WVE) is leading a revolution in nucleic acid therapeutics and was founded on the core principle that medicines should possess precisely controlled molecular structures. We and our strategic partners are advancing a portfolio of stereopure drug candidates that target underlying biology across a wide range of human diseases.
Profile
WaVe Life Sciences LinkedIn Company Profile
Social Media
WaVe Life Sciences Company Twitter Account
Company News
WaVe Life Sciences News
Facebook
WaVe Life Sciences on Facebook
YouTube
WaVe Life Sciences on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Paul Bolno
  Paul Bolno LinkedIn Profile  Paul Bolno Twitter Account  Paul Bolno News  Paul Bolno on Facebook
Chief Medical Officer
Michael Panzara
  Michael Panzara LinkedIn Profile  Michael Panzara Twitter Account  Michael Panzara News  Michael Panzara on Facebook
Vice President
Chandra Vargeese
  Chandra Vargeese LinkedIn Profile  Chandra Vargeese Twitter Account  Chandra Vargeese News  Chandra Vargeese on Facebook
VP - Bus. Development
Chris Francis
  Chris Francis LinkedIn Profile  Chris Francis Twitter Account  Chris Francis News  Chris Francis on Facebook
VP - Finance
Kyle Moran
  Kyle Moran LinkedIn Profile  Kyle Moran Twitter Account  Kyle Moran News  Kyle Moran on Facebook


 

 

Browse more venture capital transactions:

Prev: 8/18/2015: Pacific Ag Systems venture capital transaction
Next: 8/18/2015: Helix venture capital transaction

 

Share this article

 


Where The Data Comes From

Our team works diligently to report on every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary